Who owns DIANTHUS THERAPEUTICS INC?
- Ticker: DNTH
- CUSIP Number: 252828108
Tip: Access positions for across all investors
Analyze quarterly positions in Dianthus Therapeutics with up to 7 years of data, all consolidated into one spreadsheet
Download as csv
Download as Excel
Top investors of Dianthus Therapeutics stock
Who bought or sold DIANTHUS THERAPEUTICS INC this quarter?
| Fund or Company Name | Shares Held | Valued At | Change in Shares | As Of | Actions |
|---|---|---|---|---|---|
| Bain Capital Life Sciences Investors | 3.0M | $78M | 1% | Jun 2024 |
|
| Avidity Partners Management | 2.9M | $80M | 0% | Sep 2024 |
|
| Fairmount Funds Management | 2.7M | $74M | -2% | Sep 2024 |
|
| RA Capital Management | 2.3M | $64M | 0% | Sep 2024 |
|
| Octagon Capital Advisors | 1.7M | $48M | 0% | Sep 2024 |
|
| VR Adviser | 1.7M | $48M | -17% | Sep 2024 |
|
| BlackRock | 1.6M | $45M | 100% | Sep 2024 |
|
| BlackRock | 1.6M | $42M | 3340% | Jun 2024 |
|
| Vanguard Group | 1.2M | $32M | 132% | Jun 2024 |
|
| 5AM Venture Management | 1.2M | $34M | 0% | Sep 2024 |
|
| Henderson Group | 676k | $18M | 80% | Jun 2024 |
|
| Braidwell | 494k | $14M | 35% | Sep 2024 |
|
| Geode Capital Management | 485k | $13M | -3% | Sep 2024 |
|
| Point72 Asset Management | 438k | $12M | 151% | Sep 2024 |
|
| State Street Corporation | 408k | $11M | 1899% | Jun 2024 |
|
| Vestal Point Capital | 395k | $11M | -34% | Sep 2024 |
|
| Dr. Jeffrey R. Jay, M.D. | 275k | $7.5M | -64% | Sep 2024 |
|
| Tang Capital Management | 265k | $7.2M | 0% | Sep 2024 |
|
| Woodline Partners | 251k | $6.9M | 0% | Sep 2024 |
|
| Alphabet | 209k | $5.7M | 0% | Sep 2024 |
|
| Northern Trust | 203k | $5.5M | 996% | Sep 2024 |
|
| Charles Schwab Investment Management | 166k | $4.5M | 142% | Sep 2024 |
|
| Atlas Venture Life Science Advisors | 137k | $3.5M | -27% | Jun 2024 |
|
| Bank of America Corporation | 88k | $2.4M | 379% | Sep 2024 |
|
| Nuveen Asset Management | 87k | $2.2M | 100% | Jun 2024 |
|
| Bank of New York Mellon | 73k | $2.0M | -10% | Sep 2024 |
|
| Citadel Advisors | 60k | $1.6M | 100% | Sep 2024 |
|
| Renaissance Technologies | 55k | $1.5M | -37% | Sep 2024 |
|
| Marshall Wace | 54k | $1.5M | -50% | Sep 2024 |
|
| Cubist Systematic Strategies | 50k | $1.4M | 140% | Sep 2024 |
|
| American Century Companies | 42k | $1.2M | 39% | Sep 2024 |
|
| Goldman Sachs Group | 42k | $1.1M | -75% | Jun 2024 |
|
| Barclays | 42k | $1.1M | 390% | Sep 2024 |
|
| Pnc Financial Services | 37k | $1.0M | 0% | Sep 2024 |
|
| Rhumbline Advisers | 35k | $948k | 8% | Sep 2024 |
|
| Rafferty Asset Management | 31k | $839k | 100% | Sep 2024 |
|
| Royal Bank of Canada | 29k | $998k | 1142% | Sep 2024 |
|
| Morgan Stanley | 27k | $698k | 28% | Jun 2024 |
|
| Alliancebernstein | 25k | $647k | 100% | Jun 2024 |
|
| Alpine Partners VI | 23k | $605k | 100% | Jun 2024 |
|
| ALPS Advisors | 22k | $611k | 100% | Sep 2024 |
|
| Wells Fargo & Company | 22k | $605k | 114% | Sep 2024 |
|
| Arrowpoint Asset Management | 21k | $569k | 0% | Sep 2024 |
|
| Jane Street | 20k | $556k | 100% | Sep 2024 |
|
| Citigroup | 17k | $476k | 186% | Sep 2024 |
|
| Swiss National Bank | 17k | $474k | 0% | Sep 2024 |
|
| Bessemer | 15k | $406k | 0% | Sep 2024 |
|
| Mirae Asset Global Etfs Holdings | 14k | $393k | 100% | Sep 2024 |
|
| MetLife Investment Advisors | 14k | $382k | 129% | Sep 2024 |
|
| Deutsche Bank Aktiengesellschaft | 13k | $351k | 36% | Sep 2024 |
|
| Point72 | 13k | $342k | -3% | Sep 2024 |
|
| Qube Research & Technologies | 11k | $290k | -83% | Jun 2024 |
|
| Invesco | 11k | $294k | -4% | Sep 2024 |
|
| Jpmorgan Chase & Co | 11k | $291k | 4% | Sep 2024 |
|
| Two Sigma Investments | 11k | $272k | -72% | Jun 2024 |
|
| New York State Common Retirement Fund | 9.7k | $266k | 0% | Sep 2024 |
|
| Fred Alger Management | 9.6k | $264k | 52% | Sep 2024 |
|
| California State Teachers Retirement System | 9.4k | $258k | -3% | Sep 2024 |
|
| Manufacturers Life Insurance Company | 9.1k | $236k | 100% | Jun 2024 |
|
| SG Americas Securities | 8.8k | $242k | 104% | Sep 2024 |
|
| Point72 Asia | 8.6k | $235k | -78% | Sep 2024 |
|
| Ing Investment Management | 8.0k | $218k | -2% | Sep 2024 |
|
| T. Rowe Price Associates | 7.8k | $215k | 100% | Sep 2024 |
|
| Advisor Group Holdings | 3.1k | $85k | 100% | Sep 2024 |
|
| Summit Investment Advisors | 2.3k | $64k | 0% | Sep 2024 |
|
| Quest Partners | 1.1k | $31k | 112400% | Sep 2024 |
|
| Amalgamated Bank | 827.00 | $23k | 0% | Sep 2024 |
|
| Parkside Financial Bank & Trust | 385.00 | $11k | 100% | Sep 2024 |
|
| TD Waterhouse Canada | 203.00 | $5.7k | 100% | Sep 2024 |
|
| Sterling Capital Management | 78.00 | $2.1k | 100% | Sep 2024 |
|
| NISA Investment Advisors | 73.00 | $2.0k | 100% | Sep 2024 |
|
| Us Bancorp | 65.00 | $1.8k | 100% | Sep 2024 |
|
| Quarry | 33.00 | $854.000400 | 100% | Jun 2024 |
|
| Rothschild Investment | 20.00 | $548.000000 | 300% | Sep 2024 |
|
| Lindbrook Capital | 17.00 | $464.999300 | 100% | Sep 2024 |
|
| GAMMA Investing | 6.00 | $163.999800 | 100% | Sep 2024 |
|
| CWM | 5.00 | $0 | 100% | Sep 2024 |
|
| Institutional & Family Asset Management | 3.00 | $78.000000 | 0% | Jun 2024 |
|
Who sold out of Dianthus Therapeutics?
| Fund or Company Name | Date Sold | Shares Held | Valued At |
|---|---|---|---|
| Soleus Capital Management | Mar 2024 | 100k | $3.0M |
| Dimensional Fund Advisors | Jun 2024 | 20k | $511k |
| ExodusPoint Capital Management | Mar 2024 | 17k | $510k |
| Squarepoint Ops | Mar 2024 | 14k | $409k |
| Balyasny Asset Management | Mar 2024 | 13k | $401k |
| Winton Capital | Jun 2024 | 10k | $265k |
| Leucadia National Corporation | Mar 2024 | 7.6k | $228k |
| Tower Research Capital | Mar 2024 | 3.9k | $117k |
| Macquarie Group | Mar 2024 | 1.8k | $55.084800 |